Skip to main content

previous disabled Page of 3
and
  1. No Access

    Article

    Spatial genomic, biochemical and cellular mechanisms underlying meningioma heterogeneity and evolution

    Intratumor heterogeneity underlies cancer evolution and treatment resistance, but targetable mechanisms driving intratumor heterogeneity are poorly understood. Meningiomas are the most common primary intracran...

    Calixto-Hope G. Lucas, Kanish Mirchia, Kyounghee Seo, Hinda Najem in Nature Genetics (2024)

  2. Article

    Open Access

    “De novo replication repair deficient glioblastoma, IDH-wildtype” is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade

    Glioblastoma is a clinically and molecularly heterogeneous disease, and new predictive biomarkers are needed to identify those patients most likely to respond to specific treatments. Through prospective genomi...

    Sara Hadad, Rohit Gupta, Nancy Ann Oberheim Bush, Jennie W. Taylor in Acta Neuropathologica (2023)

  3. Article

    Open Access

    Somatic mosaic SOX10 indel mutations underlie a form of segmental schwannomatosis

    Merryl Terry, Rohit Gupta, Ajay Ravindranathan, Jasper Wu in Acta Neuropathologica (2023)

  4. No Access

    Article

    Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses

    Surgery is the mainstay of treatment for meningioma, the most common primary intracranial tumor, but improvements in meningioma risk stratification are needed and indications for postoperative radiotherapy are...

    William C. Chen, Abrar Choudhury, Mark W. Youngblood, Mei-Yin C. Polley in Nature Medicine (2023)

  5. Article

    Open Access

    Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas

    Vivian Tang, Rufei Lu, Kanish Mirchia, Jessica Van Ziffle in Acta Neuropathologica (2023)

  6. Article

    Open Access

    Correction to: Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification

    Michaela-Kristina Keck, Martin Sill, Andrea Wittmann, Piyush Joshi in Acta Neuropathologica (2023)

  7. Article

    Open Access

    Amplification of the PLAG-family genes—PLAGL1 and PLAGL2—is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification

    Pediatric central nervous system (CNS) tumors represent the most common cause of cancer-related death in children aged 0–14 years. They differ from their adult counterparts, showing extensive clinical and mole...

    Michaela-Kristina Keck, Martin Sill, Andrea Wittmann, Piyush Joshi in Acta Neuropathologica (2023)

  8. Article

    Open Access

    Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1

    Gliomas arising in the setting of neurofibromatosis type 1 (NF1) are heterogeneous, occurring from childhood through adulthood, can be histologically low-grade or high-grade, and follow an indolent or aggressi...

    Calixto-Hope G. Lucas, Emily A. Sloan, Rohit Gupta, Jasper Wu in Acta Neuropathologica (2022)

  9. Article

    Open Access

    Conserved features of TERT promoter duplications reveal an activation mechanism that mimics hotspot mutations in cancer

    Mutations in the TERT promoter represent the genetic underpinnings of tumor cell immortality. Beyond the two most common point mutations, which selectively recruit the ETS factor GABP to activate TERT, the signif...

    Carter J. Barger, Abigail K. Suwala, Katarzyna M. Soczek in Nature Communications (2022)

  10. No Access

    Article

    Intratumor and informatic heterogeneity influence meningioma molecular classification

    Harish N. Vasudevan, Abrar Choudhury, Stephanie Hilz in Acta Neuropathologica (2022)

  11. No Access

    Article

    Recurrent ACVR1 mutations in posterior fossa ependymoma

    Drew Pratt, Calixto-Hope G. Lucas, Pavalan Panneer Selvam in Acta Neuropathologica (2022)

  12. No Access

    Article

    Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities

    Meningiomas are the most common primary intracranial tumors. There are no effective medical therapies for meningioma patients, and new treatments have been encumbered by limited understanding of meningioma bio...

    Abrar Choudhury, Stephen T. Magill, Charlotte D. Eaton, Briana C. Prager in Nature Genetics (2022)

  13. Article

    Open Access

    Activating NTRK2 and ALK receptor tyrosine kinase fusions extend the molecular spectrum of pleomorphic xanthoastrocytomas of early childhood: a diagnostic overlap with infant-type hemispheric glioma

    Calixto-Hope G. Lucas, Zied Abdullaev, Carol S. Bruggers in Acta Neuropathologica (2022)

  14. Article

    Open Access

    EWSR1-BEND2 fusion defines an epigenetically distinct subtype of astroblastoma

    Calixto-Hope G. Lucas, Rohit Gupta, Jasper Wu, Kathan Shah in Acta Neuropathologica (2022)

  15. Article

    Open Access

    Genetic and epigenetic characterization of posterior pituitary tumors

    Pituicytoma (PITUI), granular cell tumor (GCT), and spindle cell oncocytoma (SCO) are rare tumors of the posterior pituitary. Histologically, they may be challenging to distinguish and have been proposed to re...

    Simone Schmid, David A. Solomon, Eilis Perez, Anne Thieme in Acta Neuropathologica (2021)

  16. Article

    Open Access

    Low-grade glioneuronal tumors with FGFR2 fusion resolve into a single epigenetic group corresponding to ‘Polymorphous low-grade neuroepithelial tumor of the young’

    Rohit Gupta, Calixto-Hope G. Lucas, Jasper Wu, Jairo Barreto in Acta Neuropathologica (2021)

  17. No Access

    Article

    The immunohistochemical, DNA methylation, and chromosomal copy number profile of cauda equina paraganglioma is distinct from extra-spinal paraganglioma

    Paragangliomas are neuroendocrine tumors of the autonomic nervous system that are variably clinically functional and have a potential for metastasis. Up to 40% occur in the setting of a hereditary syndrome, mo...

    Biswarathan Ramani, Rohit Gupta, Jasper Wu, Jairo Barreto in Acta Neuropathologica (2020)

  18. Article

    Open Access

    Comprehensive analysis of diverse low-grade neuroepithelial tumors with FGFR1 alterations reveals a distinct molecular signature of rosette-forming glioneuronal tumor

    The FGFR1 gene encoding fibroblast growth factor receptor 1 has emerged as a frequently altered oncogene in the pathogenesis of multiple low-grade neuroepithelial tumor (LGNET) subtypes including pilocytic astroc...

    Calixto-Hope G. Lucas, Rohit Gupta, Pamela Doo in Acta Neuropathologica Communications (2020)

  19. Article

    Open Access

    DNA methylation profiling demonstrates superior diagnostic classification to RNA-sequencing in a case of metastatic meningioma

    Meningiomas are the most common primary intracranial tumors, but meningioma metastases are rare. Accordingly, the clinical workup, diagnostic testing, and molecular classification of metastatic meningioma is i...

    Harish N. Vasudevan, Maria R. H. Castro in Acta Neuropathologica Communications (2020)

  20. No Access

    Article

    Pediatric bithalamic gliomas have a distinct epigenetic signature and frequent EGFR exon 20 insertions resulting in potential sensitivity to targeted kinase inhibition

    Brain tumors are the most common solid tumors of childhood, and the genetic drivers and optimal therapeutic strategies for many of the different subtypes remain unknown. Here, we identify that bithalamic gliom...

    Gourish Mondal, Julieann C. Lee, Ajay Ravindranathan in Acta Neuropathologica (2020)

previous disabled Page of 3